Loading company…
Riskpilot
← Back to search
Sign in
Get full access
DR. WANG AS
AS
Active
Org 925273848
Tors Vei 16, 1464 Fjellhamar
General medical practice activities · NACE 8621
Est. 2020
2 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2025
NOK 7M
+3% vs 2024
EBITDA margin
37.1%
+9% vs 2024
Equity ratio
61.0%
Financial strength
Net profit 2025
NOK 1,6M
+6% vs 2024
EBITDA — year on year
NOK millions
0M
1M
2M
3M
4M
0M
2020
1M
+100%
2021
0M
-100%
2022
2M
+200%
2023
2M
0%
2024
3M
+50%
2025
Key figures
Annual report 2025
Revenue
NOK 7M
+3%
EBITDA
NOK 2,6M
+9%
Net profit
NOK 1,6M
+6%
Total assets
NOK 4,6M
+32%
Equity
NOK 2,8M
+26%
Employees
2
—
Company information
Legal name
DR. WANG AS
Org number
925273848
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
28. juli 2020
Share capital
NOK 30 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Company purpose
Allmenn legetjeneste.
Contact
Address
Tors Vei 16, 1464 Fjellhamar
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in General medical practice activities
Companies in Lørenskog
All Norway companies
Revenue
NOK millions
0M
2M
4M
6M
8M
1M
2020
3M
2021
3M
2022
5M
2023
7M
2024
7M
2025
EBITDA
NOK millions
0M
1M
2M
3M
3M
0M
2020
1M
2021
0M
2022
2M
2023
2M
2024
3M
2025
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
2025
Revenue
510
2 559
2 764
5 284
6 788
6 990
Staff expenses
−0
−196
−679
−1 086
−1 700
−1 879
EBITDA
237
1 083
490
1 861
2 378
2 591
Depreciation & amort.
−13
−278
−290
−369
−455
−566
EBIT
224
805
200
1 491
1 923
2 026
Net financials
0
−20
−14
−26
−12
0
Profit before tax
224
785
185
1 466
1 911
2 026
Tax
49
173
41
322
421
448
Net profit
175
612
145
1 143
1 490
1 578
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
2025
Total assets
1 315
1 855
1 909
2 298
3 473
4 594
Equity
35
647
791
1 235
2 225
2 803
Long-term debt
1 041
959
883
284
70
62
Short-term debt
239
249
235
780
1 178
1 729
Total debt
1 280
1 208
1 118
1 064
1 248
1 791
Financial ratios
5-year trend
EBITDA margin
37.1%
This company
15.8%
Market median
+135% vs market
2020
2025
Equity ratio
61.0%
This company
38.2%
Market median
+60% vs market
2020
2025
Return on equity
56.3%
This company
18.4%
Market median
+206% vs market
2020
2025
Net profit margin
22.6%
This company
8.1%
Market median
+179% vs market
2020
2025
Asset turnover
1.52×
This company
1.12×
Market median
+36% vs market
2020
2025
Debt / equity
0.64×
This company
0.62×
Market median
+3% vs market
2020
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-06-22 – 2020-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
YW
Ying Wang
Chief Executive Officer
Chief Executive Officer
2020
—
—
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of DR. WANG AS also hold positions in
0
other companies.
Person
Role here
Other companies
Ying Wang
Chief Executive Officer
0 companies